1.Research progress of irradiation injuries anti-agents.
Ya Nan DU ; Xue Ying YANG ; Qiang ZENG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2023;41(3):237-240
Irradiation injuries anti-agents refer to drugs that can inhibit the initial stage of radiation injuries, or reduce the development of radiation injuries and promote the recovery of injuries when used early after irradiation exposure. According to the mechanism of action and the time of intervention, the irradiation injuries anti-agents are divided into four categories: radioprotectors, radiomitigators, radiation therapeutics for external radiation exposure, and anti-agents for internalized radionuclides. In this paper, the research progress of irradiation injuries anti-agents in recent years is reviewed.
Humans
;
Radiation-Protective Agents/therapeutic use*
;
Radiation Injuries/prevention & control*
2.Mechanism and problem of amifostine in treating myelodysplastic syndromes.
Yan-Hui DANG ; Wei LI ; Bo YANG ; Hong-Li ZHU ; Yu HUANG
Journal of Experimental Hematology 2009;17(6):1597-1601
Myelodysplastic syndrome (MDS) is one of the most prevalent haematological malignancies originating from haemopoietic stem/progenitor cells. MDS characterized by morbid haematopoiesis of bone marrow and peripheral blood cell reduction and mainly occurs in the elders. The dangerous factors of MDS include chemotherapy, radiotherapy, benzene, other organic solvent, immune depressants and so on. Following the recent progress of medical sciences, a large number of new regimens of chemotherapy, radiotherapy and immune therapy against carcinomas generate and lead the development of therapeutics for malignancies. It is worried that the incidence of MDS still increases year by year and the patient age becomes younger. Although many agents are used to MDS, curative effect is not as good as expect. Amifostine, a kind of pancytoprotector also used in treatment of MDS. This review summarizes the mechanism of amifostine in MDS therapy which possesses a challenge binding with the current related investigations.
Amifostine
;
therapeutic use
;
Humans
;
Myelodysplastic Syndromes
;
drug therapy
;
Radiation-Protective Agents
;
therapeutic use
3.Plant-based Rasayana drugs from Ayurveda.
Subramani Paranthaman BALASUBRAMANI ; Padma VENKATASUBRAMANIAN ; Subrahmanya Kumar KUKKUPUNI ; Bhushan PATWARDHAN
Chinese journal of integrative medicine 2011;17(2):88-94
Rasayana tantra is one of the eight specialties of Ayurveda. It is a specialized practice in the form of rejuvenative recipes, dietary regimen, special health promoting behaviour and drugs. Properly administered Rasayana can bestow the human being with several benefits like longevity, memory, intelligence, freedom from diseases, youthful age, excellence of luster, complexion and voice, optimum strength of physique and sense organs, respectability and brilliance. Various types of plant based Rasayana recipes are mentioned in Ayurveda. Review of the current literature available on Rasayanas indicates that anti-oxidant and immunomodulation are the most studied activities of the Rasayana drugs. Querying in Pubmed database on Rasayanas reveals that single plants as well as poly herbal formulations have been researched on. This article reviews the basics of Rasayana therapy and the published research on different Rasayana drugs for specific health conditions. It also provides the possible directions for future research.
Animals
;
Anti-Ulcer Agents
;
pharmacology
;
therapeutic use
;
Antineoplastic Agents, Phytogenic
;
pharmacology
;
therapeutic use
;
Antiparasitic Agents
;
pharmacology
;
therapeutic use
;
Aphrodisiacs
;
pharmacology
;
therapeutic use
;
Free Radical Scavengers
;
pharmacology
;
therapeutic use
;
Giardiasis
;
drug therapy
;
Herbal Medicine
;
classification
;
methods
;
trends
;
Humans
;
Immunologic Factors
;
pharmacology
;
therapeutic use
;
Medicine, Ayurvedic
;
Models, Biological
;
Neuroprotective Agents
;
pharmacology
;
therapeutic use
;
Plant Preparations
;
classification
;
therapeutic use
;
Radiation-Protective Agents
;
pharmacology
;
therapeutic use
4.Ethnomedicinal, phytochemical and pharmacological updates on Hygrophila auriculata (Schum.) Hiene: an overview.
Neeraj K SETHIYA ; Nasir M AHMED ; Raeesh M SHEKH ; Vivek KUMAR ; Pawan Kumar SINGH ; Vipin KUMAR
Journal of Integrative Medicine 2018;16(5):299-311
This article explores the most recent evidence-based information on ethnomedicinal, phytochemical and pharmacological understanding of Hygrophila auriculata for the treatment of various diseases and health conditions. Various ethnomedicinal writings suggest the use of the plant or its parts for the treatment of jaundice, oedema, gastrointestinal ailments, diarrhoea, dysentery, urinogenital disorder, gall stones, urinary calculi, kidney stone, leucorrhoea, rheumatism, tuberculosis, anaemia, body pain, constipation, skin disease, and as an aphrodisiac. The plant has been reported to contain flavonoids (apigenin, luteolin, ellagic acid, gallic acid and quercetin), alkaloids (asteracanthine and asteracanthicine), triterpenes (lupeol, lupenone, hentricontane and betulin), sterols (stigmasterol and asterol), minerals, amino acids, fatty acids, aliphatic esters and essential oils. Extracts and bioactive compounds from the plant have been found to possess antimicrobial, anthelmintic, antitermite, nephroprotective, hepatoprotective, central nervous system protective, antitumour, antidiabetic, anticataract, antioxidant, haematopoietic, diuretic, antinociceptive, anti-inflammatory, antipyretic, antimotility, aphrodisiac, neuroprotection, anti-endotoxin and anti-urolithiatic activities. For this paper, we reviewed patents, clinical studies, analytical studies and marketed formulations from the earliest found examples from 1887 to the end of 2017.
Acanthaceae
;
chemistry
;
Anti-Infective Agents
;
Anti-Inflammatory Agents
;
Antioxidants
;
Ethnopharmacology
;
Humans
;
Medicine, Traditional
;
Phytochemicals
;
pharmacology
;
therapeutic use
;
Phytotherapy
;
Plant Extracts
;
pharmacology
;
therapeutic use
;
Protective Agents
6.Screening on the pharmacodynemic active parts of protecting liver of Peristrope japonica (Thunb.) Bremek.
Xixiong, YANG ; Huifang, PI ; Guoxin, ZHANG ; Xuebing, PANG ; Jizhou, WU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(5):525-7
The pharmacodynamic active parts of protecting liver of Peristrope japonica (thunb.) Bremek were identified. Rat acute liver injury model was induced by D-galactosamine (D-GlaN). The active parts were identified on the whole extraction and 4 fractions. The results showed that the pharmacodynamic active parts of Peristrope japonica were the n-BuOH fraction.
Acanthaceae
;
Drugs, Chinese Herbal/*pharmacology
;
Drugs, Chinese Herbal/therapeutic use
;
Galactosamine
;
Hepatitis, Toxic/etiology
;
Hepatitis, Toxic/*prevention & control
;
Liver Function Tests
;
Phytotherapy
;
Protective Agents/pharmacology
;
Protective Agents/therapeutic use
;
Random Allocation
7.Preparedness for Prevention of Ebola Virus Disease.
Journal of Korean Medical Science 2014;29(9):1185-1185
8.Preparedness for Prevention of Ebola Virus Disease.
Journal of Korean Medical Science 2014;29(9):1185-1185
10.Radioprotection related activities of medicinal plant.
China Journal of Chinese Materia Medica 2007;32(13):1263-1266
The development of radioprotective agents has been the subject of intense research in view of their potential for use within a radiation environment, such as space exploration, radiotherapy and even nuclear war. However, no ideal synthetic radioprotectors are available at present, so the search for alternative sources, including plants, has been on going for several decades. This article reviews some of the most promising plants, and their radioprotection related activities.
Animals
;
Drugs, Chinese Herbal
;
isolation & purification
;
therapeutic use
;
Humans
;
Phytotherapy
;
methods
;
trends
;
Plants, Medicinal
;
chemistry
;
Radiation Injuries
;
drug therapy
;
Radiation-Protective Agents
;
isolation & purification
;
therapeutic use